Antifibrotic in interstitial lung diseases: When, where, and how long?

被引：3
|
作者：
Rai, Deependra K. [1 ]
Tripathi, Suryakant [2 ]
机构：
[1] AIIMS, Dept Pulm Med, Patna, Bihar, India
[2] KJMU, Dept Pulm Med, Lucknow, Uttar Pradesh, India
来源：
LUNG INDIA | 2022年 / 39卷 / 06期
关键词：
IDIOPATHIC PULMONARY-FIBROSIS; FORCED VITAL CAPACITY; DOUBLE-BLIND; PIRFENIDONE; NINTEDANIB; EFFICACY; SAFETY; UPDATE;
D O I：
10.4103/lungindia.lungindia_283_22
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：491 / 494
页数：4
相关论文
共 50 条
  • [31] Biologic Treatments in Interstitial Lung Diseases
    Karampitsakos, Theodoros
    Vraka, Argyro
    Bouros, Demosthenes
    Liossis, Stamatis-Nick
    Tzouvelekis, Argyris
    FRONTIERS IN MEDICINE, 2019, 6
  • [32] Management of Fibrosing Interstitial Lung Diseases
    Maher, Toby M.
    Wuyts, Wim
    ADVANCES IN THERAPY, 2019, 36 (07) : 1518 - 1531
  • [33] Development and progress in interstitial lung diseases
    Buschulte, Katharina
    Heussel, Claus Peter
    Hoeger, Philipp
    Kahn, Nicolas
    Kreuter, Michael
    PNEUMOLOGE, 2022, 19 (02): : 97 - 103
  • [34] Interstitial lung diseases
    Wijsenbeek, Marlies
    Suzuki, Atsushi
    Maher, Toby M.
    LANCET, 2022, 400 (10354): : 769 - 786
  • [35] Use of pirfenidone in fibrotic interstitial lung diseases and beyond: a review
    Han, Mingfeng
    Liu, Qijia
    Ji, Zhe
    Jin, Lili
    Jin, Wenyu
    Gao, Zhonggao
    FRONTIERS IN MEDICINE, 2024, 11
  • [36] Progressive fibrosis in interstitial lung diseases - proposed definition and management
    Martusewicz-Boros, Magdalena Maria
    Piotrowski, Wojciech Jerzy
    ADVANCES IN RESPIRATORY MEDICINE, 2021, 89 (05) : 505 - 510
  • [37] A multicenter survey study of antifibrotic use for symptomatic patients with post-COVID-19 interstitial lung abnormalities
    Dhooria, Sahajal
    Maturu, Venkata Nagarjuna
    Talwar, Deepak
    Kumar, Sachin
    Handa, Ajay
    Agrawal, Priya Nath
    Jindal, Aditya
    Tampi, P. S.
    Goyal, Abhishek
    Maskey, Dipesh
    Aggarwal, Ashutosh Nath
    Behera, Digambar
    Jindal, Surinder Kumar
    LUNG INDIA, 2022, 39 (03) : 254 - 260
  • [38] Antifibrotic Agents in Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Systematic Review and Meta-Analysis
    Jang, Ji Hoon
    Ko, Junghae
    Jung, So Young
    Kim, Dae-Wook
    Oh, Ju Hyun
    Kim, Tae-Jung
    Park, Joo Hun
    Choi, Miyoung
    Lee, Jae Ha
    LIFE-BASEL, 2023, 13 (12):
  • [39] Nintedanib in Asian patients with progressive fibrosing interstitial lung diseases: Results from the INBUILD trial
    Inoue, Yoshikazu
    Wells, Athol U.
    Song, Jin Woo
    Xu, Zuojun
    Kitamura, Hideya
    Suda, Takafumi
    Okamoto, Masaki
    Mueller, Heiko
    Coeck, Carl
    Rohr, Klaus B.
    Kolb, Martin
    Brown, Kevin K.
    RESPIROLOGY, 2023, 28 (05) : 465 - 474
  • [40] Interstitial lung diseases: From imaging to treatment
    Soriano, D.
    Nattenmueller, J.
    Schroeder, K.
    Schygulla, E.
    Jouanjan, L.
    Venhoff, N.
    Jandova, I.
    Stolz, D.
    Frye, B. C.
    RADIOLOGIE, 2024, 64 (08): : 643 - 652
12345